Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales
- K. L. Hopkins(corresponding author),
- M. J. Batchelor,
- E. Liebana,
- A. P. Deheer-Graham,
- E. J. Threlfall
- ,
- Health Protection Agency,
- Animal and Plant Health Agency
Research Output:
Contribution to journal
Article
Research
Peer-reviewAbstract
<p>CTX-M and AmpC genes in human isolates of Escherichia coli, their genetic environment and their host plasmids were examined. Isolates (n = 103) were selected based on resistance (minimum inhibitory concentration (MIC) ≥ 1 μg/mL) to ceftriaxone and cefotaxime. Polymerase chain reaction (PCR) and sequencing identified 29 isolates containing bla<sub>CTX-M-15</sub>, 1 each of bla<sub>CTX-M-2</sub> (a strain originating from Israel) and bla<sub>CTX-M-40</sub>, 20 isolates containing bla<sub>CMY-7</sub>, 4 bla<sub>CMY-2</sub> and 1 bla<sub>CMY-21</sub>. This is the first study of plasmid-mediated AmpC genes in E. coli in the UK. Eleven cefoxitin-resistant, AmpC PCR-negative isolates had ampC promoter region mutations. All bla<sub>CTX-M-15</sub> and 24 of 25 bla<sub>CMY</sub> genes were associated with an ISEcp1-like element. The bla<sub>CTX-M-2</sub> was located in an orf513-bearing class 1 integron. Plasmid restriction digests suggest transfer of genes between different plasmid backbones.</p>
Research Output Information
Output type
Research Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 180-192 (13 pages)Journal (Volume, Issue Number)
International Journal of Antimicrobial Agents (Volume 28, Issue 3)Publication milestones
- Published - 09/2006
Publication status
Published - 09/2006
ISSN
0924-8579Publication IDs
- Scopus: 33747135849
- PubMed: 16879949
Funding Details
This study was funded by the Department of Food, Environment and Rural Affairs (Defra), United Kingdom (project VM02136). We would like to thank Tom Cheasty, Laboratory of Enteric Pathogens, Health Protection Agency Centre for Infections (HPA CfI), for providing the strains; and Edi Karisik, Antibiotic Resistance Monitoring and Reference Laboratory (ARMRL), HPA CfI, for help with the transformation experiments. We also thank Neil Woodford, ARMRL, HPA CfI, for contributive discussion.
FundersFunding number
Department of Food, Environment and Rural Affairs
-Defra
VM02136
Sustainable Development Goals
- SDG 3 Good Health and Well
